ILC ARTICLE

Copart great for Gatsby


Copart was the headline sponsor of the Make 2nds Count Great Gatsby Gala Ball recently, which raised more than £88,000 for research into secondary breast cancer.

Make 2nds Count is a charity dedicated to supporting women and men with secondary breast cancer.

The Gala Ball is one of its key fundraising events, bringing Scottish businesses and fundraising communities together to raise much-needed funds for essential research into incurable secondary breast cancer.

Gillian Stewart, Office Manager at Copart’s U-Pull-It Inverkeithing, who was diagnosed with breast cancer is 2020 and has organised fundraising events for Breast Cancer Now, attended the gala.

She said, “This charity is very close to my heart and the work they do is phenomenal. Lisa, the founder was diagnosed the same as me, straight to having secondary breast cancer and decided in her hospital bed that there wasn’t enough awareness of this disease, so that is where Make 2nds Count was born.”

Mark Godfrey, Director of Copart Recycling & Automotive, added: “As part of our Copart Cares CSR commitment, we’re proud to work closely with our teammates, customers, and communities to identify good causes like this, where we can help to make a real difference.

“I’m really pleased that we were able to support an event that personally meant so much to one of our teammates and play a small part in helping to raise an amazing £88,000 ,which will make such a positive difference to the lives of those living with secondary breast cancer.”

EVENTS

Upcoming Event


Motor Claims News

ILC Breakfast News – Wednesday, 27 September 2023

ARC360 | Claims Essesntials | Claims Tech | Home | ILC News | MGA | Motor | New Generation

27-09-2023

ILC motor conference set for Google exclusive

Claims Tech | ILC News | MGA | Motor | New Generation

26-09-2023

Insurer Partners

AGEAS
INSURE THE BOX

Industry Body Partners

Insights Partners

Motor Corporate Partners

ACTIVATE GROUP
BHR Assist Insurance Services
INNOVATION-GROUP
KENNEDYS
SYNETIQ